SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending after its CEO met with a former president, who praised the company's commitment to U.S. chip manufacturing and its new advanced processors. The community is actively discussing the implications of this government backing, speculating on potential major partnerships and defense contracts, as Intel is viewed as a strategic national asset in the push for domestic semiconductor production.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a focal point of investor discussion as the biotech community anticipates potential updates at the upcoming JP Morgan Healthcare Conference, with many expressing frustration over the stock's underperformance despite robust Briumvi sales and an active M&A environment. Conversations are heavily focused on Briumvi's strong market share growth and best-in-class profile, the significant potential of a future subcutaneous formulation, and persistent buyout speculation, especially as competing BTK inhibitors face recent setbacks.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid heightened drama around its proposed acquisition of Warner Bros. Discovery, with Paramount Skydance's hostile bid creating significant market uncertainty and concerns about potential debt. Despite community frustration over recent price action and perceived manipulation, many investors are actively buying the dip, anticipating a strong rebound driven by upcoming Q4 earnings and bullish AI-driven projections for subscriber and revenue growth.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited is trending due to a recently announced significant private placement and plans to acquire a TikTok star-led e-commerce platform. The community is actively discussing the stock's extremely low float and potential for a short squeeze, drawing comparisons to other high-flying Hong Kong-based IPOs. This has ignited fervent trading, with some traders touting its 'unicorn' potential while others debate the sustainability of its rapid ascent.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is trending with widespread community despair over significant losses, primarily driven by persistent warm weather forecasts that continue to suppress natural gas demand. Traders are grappling with the ETF's inherent decay and perceived market manipulation, while many hope for a bounce despite the prevailing bearish sentiment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is surging amidst intense speculation around an AI-driven memory supercycle, with reports of rising NAND flash prices and increased demand for storage solutions. This parabolic rally has ignited a heated debate among investors, as widespread bullish sentiment pushing for further gains confronts strong convictions of an impending, overvalued correction.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket Companies is trending due to President Trump's proposed $200 billion mortgage bond purchase, which is widely expected to drive mortgage rates lower and stimulate the housing market. The community is buzzing with optimism for a significant refinance and home-buying boom, anticipating a strong upward re-rating for RKT. Traders are actively discussing the potential for new highs and a substantial surge, seeing current market conditions as a perfect storm for the company's integrated platform.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following favorable FDA feedback for its lead drug, sonelokimab, enabling a Biologics License Application submission for multiple indications without additional trials. This news is driving widespread community speculation about an accelerated path to market and significant analyst upgrades. Investors are actively discussing the drug's "best-in-class" potential for inflammatory skin diseases, fueling conversations around short squeeze opportunities and potential buyout offers from major pharmaceutical companies.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is trending amid intense debate over its deep correlation to Bitcoin's performance and the recent positive MSCI index news, which many in the community believe remains undervalued. Discussions are polarized around the company's strategy of acquiring Bitcoin through share offerings, with significant options activity contributing to the stock's daily volatility.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending with community speculation centered on the alleged use of its Black Widow drones in a recent high-profile U.S. operation, igniting conversations about its role in the rapidly expanding defense sector. This immediate catalyst, coupled with anticipation for potential contract announcements at the upcoming Needham Growth Conference and the Drone Dominance Program, has intensified investor focus on RCAT's valuation and the potential for a short squeeze amidst rising global military spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SMMT  
$AKESF PR today: (not related to the summit news) 
Akeso&#39;s First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in &#39;IO+ADC&#39; 2.0 Strategy 
https://www.prnewswire.com/news-releases/akesos-first-bispecific-adc-trop2nectin4-adc-enters-clinical-trials-strengthening-leadership-in-ioadc-2-0-strategy-302497499.html

Zeke Maxwell

TruthBroker

Kyla Fisher

Quinn Mayo

Ocean Andrade

PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial...

Prnewswire

Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy

StockTwits Web

Summit Therapeutics Inc

Akeso Inc

 PR today: (not related to the summit news) 
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy 
